Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical Diabetology is Scopus-indexed (Q3, CiteScore 1.3), WoS ESCI, DOAJ. Published by Via Medica.
Checked against the index lists dated .
ISSN 2450-7458Verify ISSN ↗2450-8187Verify ISSN ↗
Publisher: Via Medica
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 122 / 179 | 32nd | Q3 |
| Endocrinology, Diabetes and Metabolism | 194 / 250 | 22nd | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q3, CiteScore 1.3.
Clinical Diabetology is Q3 in Internal Medicine (rank 122 of 179) and Q4 in Endocrinology, Diabetes and Metabolism (rank 194 of 250), by CiteScore 2025.
Clinical Diabetology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.3, which places it in quartile Q3 at the 32nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.271, quartile Q3, with an H-index of 12.
Clinical Diabetology is published by Via Medica. Its print ISSN is 2450-7458 and its online ISSN is 2450-8187.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Clinical Diabetology has an h-index of 15 and a 2-year mean of 0.52 citations per paper (OpenAlex). Its Scopus CiteScore is 1.3, quartile Q3. On 2-year citations it ranks #130 of 172 Scopus journals in Internal Medicine.
Clinical Diabetology published 51 papers in 2025; its busiest recent year was 2020 with 72. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 92 research articles (2024–2026), authors are most often from India (24.3%), Poland (23.9%) and Indonesia (8.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.